Universal Health Services Inc Revenue Growth Rates (UHS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Universal Health Services Inc   (NYSE: UHS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

UHS's Revenue Growth by Quarter and Year

Universal Health Services Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UHS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 4,638.01
1st Quarter March 4,495.18
FY 9,133.19

UHSs Annual Revenue
Universal Health Services Inc 's Revenue in the fiscal year 2025 $ 17,364.83 millions
Universal Health Services Inc 's Revenue in the fiscal year 2024 $ 15,827.94 millions
Universal Health Services Inc 's Revenue in the fiscal year 2023 $ 14,281.98 millions
Universal Health Services Inc 's Revenue in the fiscal year 2022 $ 13,399.37 millions
Universal Health Services Inc 's Revenue in the fiscal year 2021 $ 12,642.12 millions




UHS Revenue second quarter 2026 Y/Y Growth Comment
Universal Health Services Inc achieved in the second quarter 2026, above Company average Revenue improvement of 8.27% year on year, to $ 4,638.01 millions.

Looking into second quarter 2026 results within Healthcare Facilities industry 24 other companies have achieved higher Revenue growth. While Universal Health Services Inc ' s Revenue increase of 8.27% ranks overall at the positon no. 2322 in the second quarter 2026.


UHS Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 9.05 % 11.08 % 7.44 %
3rd Quarter September - 13.43 % 11.23 % 6.8 %
2nd Quarter June 8.27 % 9.63 % 10.13 % 6.76 %
1st Quarter March 9.65 % 6.66 % 10.85 % 5.3 %
FY   - 9.71 % 10.82 % -

Financial Statements
Universal Health Services Inc 's second quarter 2026 Revenue $ 4,638.01 millions UHS's Income Statement
Universal Health Services Inc 's second quarter 2025 Revenue $ 4,283.82 millions Quarterly UHS's Income Statement


UHS Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -0.2 % 3.8 % 3.95 %
3rd Quarter September - 4.94 % 1.42 % 0.41 %
2nd Quarter June 3.18 % 4.49 % 1.67 % 2.33 %
1st Quarter March 0.2 % -0.34 % 3.78 % 0.6 %
FY (Year on Year)   - 9.71 % 10.82 % -


Back to UHS Growth rate Comparisons >> Back to UHS Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #25
Healthcare Sector #337
Overall #2322

Revenue Y/Y Growth Statistics
High Average Low
31.56 % 8.22 % -18.94 %
(Sep 30 2019)   (Sep 30 2020)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #25
Healthcare Sector #337
Overall #2322
Revenue Y/Y Growth Statistics
High Average Low
31.56 % 8.22 % -18.94 %
(Sep 30 2019)   (Sep 30 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Universal Health Services Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
109.25 % 2.82 % -49.41 %
(Dec 31 2018)  


UHS's II. Quarter Q/Q Revenue Comment
Universal Health Services Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 3.18%, to $ 4,638.01 millions, from $4,495.18 millions in the first quarter.

Within Healthcare Facilities industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Universal Health Services Inc 's Revenue growth quarter on quarter, overall rank is 1300.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #184
Overall #1300
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #184
Overall #1300
Revenue Q/Q Growth Statistics
High Average Low
109.25 % 2.82 % -49.41 %
(Dec 31 2018)  


UHS's II. Quarter Q/Q Revenue Comment
Universal Health Services Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 3.18%, to $ 4,638.01 millions, from $4,495.18 millions in the first quarter.

Within Healthcare Facilities industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Universal Health Services Inc 's Revenue growth quarter on quarter, overall rank is 1300.


Universal Health Services Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 18,114.49 $ 17,760.29 $ 17,364.83 $ 16,992.50 $ 16,460.29
Y / Y Revenue Growth (TTM) 10.05 % 10.42 % 9.71 % 10.21 % 9.61 %
Year on Year Revenue Growth Overall Ranking # 1505 # 1141 # 885 # 1048 # 1029
Seqeuential Revenue Change (TTM) 1.99 % 2.28 % 2.19 % 3.23 % 2.34 %
Seq. Revenue Growth (TTM) Overall Ranking # 2322 # 2298 # 1930 # 1631 # 1497


Cumulative Revenue growth Comment
Assuming the Universal Health Services Inc 's fiscal year would have ended in Jun 30 2026, Universal Health Services Inc would have reprted above average annual Revenue increase of 10.05% year on year, of $ 18,114 millions.
This marks a slow-down of the companys growth trends and from the 10.42% rise in Mar 31 2026.

In the Healthcare sector 250 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1141 to 1505.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 251
Overall # 1505

Revenue TTM Y/Y Growth Statistics
High Average Low
31.56 %
 8.22 %
-18.94 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 337
S&P 500 # 2322
Cumulative Revenue growth Comment
Assuming the Universal Health Services Inc 's fiscal year would have ended in Jun 30 2026, Universal Health Services Inc would have reprted above average annual Revenue increase of 10.05% year on year, of $ 18,114 millions.
This marks a slow-down of the companys growth trends and from the 10.42% rise in Mar 31 2026.

In the Healthcare sector 250 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1141 to 1505.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 251
Overall # 1505

Revenue TTM Y/Y Growth Statistics
High Average Low
31.56 %
8.22 %
-18.94 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 337
S&P 500 # 2322




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
UHS's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Sbc Medical Group Holdings Incorporated14.36%$ 14.363 millions
Nuwellis Inc 14.14%$ 14.145 millions
West Pharmaceutical Services Inc 13.89%$ 13.892 millions
Edwards Lifesciences Corporation13.66%$ 13.657 millions
Indivior Pharmaceuticals Inc 13.58%$ 13.576 millions
Talkspace Inc 13.56%$ 13.556 millions
Atricure Inc 13.38%$ 13.376 millions
Dexcom Inc 13.11%$ 13.105 millions
Sanara Medtech Inc 13.03%$ 13.028 millions
Bausch Health Companies Inc 12.73%$ 12.727 millions
Vertex Pharmaceuticals Inc12.45%$ 12.453 millions
Genedx Holdings Corp 12.30%$ 12.304 millions
Profound Medical Corp 12.30%$ 12.302 millions
Xenetic Biosciences Inc 11.99%$ 11.986 millions
Biolife Solutions Inc 11.98%$ 11.978 millions
Repligen Corp11.93%$ 11.933 millions
Medline Inc 11.60%$ 11.603 millions
Earth Science Tech Inc 11.56%$ 11.556 millions
Immucell Corporation11.50%$ 11.501 millions
Harrow Inc 11.26%$ 11.256 millions
Rapid Micro Biosystems Inc 10.91%$ 10.906 millions
Livanova Plc10.80%$ 10.797 millions
Cerus Corporation10.52%$ 10.517 millions
Interpace Biosciences Inc 10.33%$ 10.331 millions
Warby Parker Inc 10.25%$ 10.253 millions
Neuronetics Inc 10.25%$ 10.249 millions
Elanco Animal Health Incorporated10.23%$ 10.234 millions
Quest Diagnostics Inc10.21%$ 10.214 millions
Gilead Sciences Inc 10.18%$ 10.181 millions
Lifeloc Technologies Inc 10.16%$ 10.163 millions


About Universal Health Services Inc Revenue Growth Rates (UHS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Universal Health Services Inc (CIK 352915).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-340278
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Universal Health Services Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.